Fresh Tracks Therapeutics Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Bert Marchio
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 3.4yrs |
CEO ownership | n/a |
Management average tenure | 2.6yrs |
Board average tenure | 2.3yrs |
Recent management updates
Recent updates
Brickell Biotech changes name to Fresh Tracks Therapeutics
Sep 07Brickell Biotech GAAP EPS of -$0.01 beats by $1.43, revenue of $4.32M beats by $1.18M
Aug 11Brickell Biotech regains Nasdaq compliance for minimum bid price requirement
Jul 20Here's Why Brickell Biotech (NASDAQ:BBI) Must Use Its Cash Wisely
Feb 14Brickell Biotech Advances To Phase III As It Eyes Commercialization
May 10Brickell Biotech completes patient enrollment in late-stage sweat disorder study
Apr 27Brickell Biotech's(NASDAQ:BBI) Share Price Is Down 16% Over The Past Year.
Jan 06Brickell Biotech (BBI) Investor Presentation - Slideshow
Dec 02Brickell Bio to launch sofpironium bromide gel, 5% in Japan on November 26
Nov 18CEO
Bert Marchio (71 yo)
3.4yrs
Tenure
Mr. Albert Nicholas Marchio, II, also known as Bert, is Interim Chief Financial Officer & Principal Accounting officer of NexImmune, Inc. since April 16, 2024. He serves as Chief Financial Officer at Fresh...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, CFO | 3.4yrs | no data | no data | |
Vice President of Corporate Development & Operations | no data | no data | no data | |
VP of Finance & Chief Accounting Officer | 1.3yrs | no data | 0% $ 0 | |
Head of Human Resource | 3.1yrs | no data | no data | |
Interim Head of CMC Development | 2.1yrs | no data | no data |
2.6yrs
Average Tenure
Experienced Management: FRTX's management team is considered experienced (2.6 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, CFO | less than a year | no data | no data | |
Member of Scientific Advisory Board | 2.3yrs | no data | no data | |
Member of Scientific Advisory Board | 2.3yrs | no data | no data | |
Member of Scientific Advisory Board | 2.3yrs | no data | no data | |
Member of Scientific Advisory Board | 2.3yrs | no data | no data | |
Member of Scientific Advisory Board | 2.3yrs | no data | no data |
2.3yrs
Average Tenure
Experienced Board: FRTX's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.